Fundraising Fox

Laia Crespo

Investor

Partner at Sanofi Ventures

Paris, France

Writes $5M – $10M checks · typically $7.5M

About

Laia Crespo, a Cambridge PhD with chemistry training, sits on the boards of QurAlis, Therini Bio and Muna Therapeutics and architects new companies around neurodegeneration and genetic medicines.

Invests in

AI & Machine LearningBiotechData & InfrastructureHealthtechMedical Devices

Experience

  1. SanofiPartner - Sanofi Venturescurrent2018 — presentParis
  2. Ysios CapitalInvestment Director2015 — 2018
  3. Ysios CapitalInvestment Manager2009 — 2015Barcelona, Catalonia, Spain
  4. Johnson & JohnsonNew Business Development Analyst for Europe, Middle East and Africa2008 — 2009
  5. UCBResearch Scientist2007Cambridge, England, United Kingdom
  6. Medivir ABResearch Scientist2004 — 2007Cambridgeshire, England, United Kingdom
  7. Spirogen (now AstraZeneca)Research Scientist2002 — 2003London, England, United Kingdom

Education

  1. University of CambridgeMBA, Master in Business Administration
  2. Universitat de BarcelonaFirst Degree, MSc and PhD
  3. Liceu Music ConservatoireBachelors Degree, Piano and Music Theory

Same school

Shared employers

Colleagues at Sanofi Ventures

Network4

Investors connected to Laia in public investor directories — a warm-intro map.